Article

Bladder cancer organoids as a functional system to model different disease stages and therapy response

2022-04-01

Abstract excerpt

Bladder Cancer (BLCa) inter-patient heterogeneity is considered the primary cause of tumor reoccurrence and treatment failure, suggesting that BLCa patients could benefit from a more personalized treatment approach. Patient-derived organoids (PDOs) have been successfully used as a functional model for predicting drug response in different cancer types. In our study, we established BLCa PDO cultures from different...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 435835e2-0bb0-5cb6-bfda-ade0c2bdf34c
DOI: 10.1101/2022.03.31.486514

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Bladder cancer organoids as a functional system to model different disease stages and therapy responseDOI 10.1101/2022.03.31.486514Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

Bladder cancer organoids as a functional system to model different disease stages and therapy responseSemantic proximity Read

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.Semantic proximity Read

Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening.Semantic proximity Read

Urine-derived bladder cancer organoids (urinoids) as tool for cancer longitudinal response monitoring and therapy adaptationSemantic proximity Read

A bladder cancer patient-derived xenograft displays aggressive growth dynamics in vivo and in organoid cultureSemantic proximity Read

Patient‐Derived Upper Tract Urothelial Carcinoma Organoids as a Platform for Drug ScreeningSemantic proximity Read

Establishing a Canine Urothelial Organoid Repository: A Platform for Comparative and Translational Carcinoma StudiesSemantic proximity Read

Patient-derived urachal cancer organoids for personalized drug screeningSemantic proximity Read

Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine ResponseSemantic proximity Read

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities.Semantic proximity Read

FOLLOW-U; study protocol evaluating oncological systemic treatment response of advanced bladder cancer patients using urinoidsSemantic proximity Read